TY  - GEN
AU  - Young,R J
AU  - Tin,A W
AU  - Brown,N J
AU  - Jitlal,M
AU  - Lee,S M
AU  - Woll,P J
TI  - Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide
SN  - 1532-1827
PY  - 2012///0516
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Biomarkers, Tumor
KW  - blood
KW  - Carboplatin
KW  - administration & dosage
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Clinical Trials, Phase III as Topic
KW  - Deoxycytidine
KW  - Etoposide
KW  - Female
KW  - Fibroblast Growth Factor 2
KW  - Humans
KW  - Intercellular Adhesion Molecule-1
KW  - Interleukin-8
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Multicenter Studies as Topic
KW  - Multivariate Analysis
KW  - Neovascularization, Pathologic
KW  - Proportional Hazards Models
KW  - Randomized Controlled Trials as Topic
KW  - Small Cell Lung Carcinoma
KW  - Survival Analysis
KW  - Thalidomide
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
KW  - Gemcitabine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/bjc.2012.50
ER  -